|Basic InformationMore InformationTestsLatest News|Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.U.S. Antidepressant Use Jumps 65 Percent in 15 YearsSmoking During Pregnancy Up Among Women With DepressionDepression After Coronary Artery Disease Diagnosis Ups Death RiskYoga May Help Ease DepressionLonger Estrogen Exposure May Protect Against DepressionEstrogen May Influence Women's Depression RiskLosing Medicaid Tough on People Battling Depression: StudyAddition of Aripiprazole Ups Major Depressive Disorder RemissionNo Sign That Antidepressants in Pregnancy Harm Kids' Brains: StudyMed Switch Not Always Best Choice With Tough DepressionDepression Contributes to Health Decline Seen in Cancer CaregiversDepression May Worsen Health for Cancer CaregiversElectric Brain Stimulation No Better Than Meds For Depression: StudyDepression Inversely Linked to Body Composition in TeensReview: Depression Screening As Inpatient Important, FeasibleDepression Can Slow Hospital Patients' Recovery: StudyAntidepressants During Pregnancy Safe for Baby: StudyWhat You Need to Know About AntidepressantsAPA: Internet-Based CBT Can Be Helpful in DepressionCan Online Treatment Replace Your Therapist?Depression Often a Precursor to Falls in Elderly PeopleObesity, Sex Predict Remission for Antidepressant MedicationsGender Differences in Depression Tend to Appear About Age 12Depression's Gender Gap Shows Up in Pre-Teen YearsStudies Question Link Between Mom's Antidepressant Use, Autism in KidsTrauma as a Teen May Boost Depression Risk Around MenopauseBlood Test Promising for ID of Early Depression, SchizophreniaBlood Test Might Someday Distinguish Early Depression, SchizophreniaHold That Pose: Yoga May Ease Tough DepressionDepression May Hasten Death in Years After Heart DiagnosisAntidepressant Efficacy Varies for Depressive Symptom ClustersDepressed Psoriasis Patients at Higher Risk of Psoriatic ArthritisCan Depression Up Odds for Arthritis Linked to Psoriasis?Postpartum Depressive Symptoms Fell in 2004 to 2012Depression Often Untreated in Dialysis PatientsPostpartum Depression Affects New Dads, TooPanic Disorder May Up Odds of Depression Rx Side EffectsSometimes the Holidays Aren't Always JollyPilots Suffer Depression, Suicidal Thoughts at Fairly High RatesMore Than 1 in 10 Pilots Suffer From Depression, Survey FindsSelf-Care Tools Cut Depression in AMD, Diabetic RetinopathyDepression, Suicide Ideation Prevalent in Medical StudentsDepression on the Rise Among U.S. Teens, Especially GirlsDepressive Symptoms Linked to Functional Status in CADHigh Rate of Antidepressant Use After CancerResearchers Find Antidepressant Bupropion Crosses PlacentaMom-to-Be's Antidepressant Use May Be Tied to Speech Issues in ChildDepression Can Fuel Heart Disease in Midlife Women: StudyDepression Common in Patients With Chronic AnginaQuestions and AnswersVideosLinksBook Reviews
Mom-to-Be's Antidepressant Use May Be Tied to Speech Issues in Child
by -- Robert Preidt
Updated: Oct 12th 2016
WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- Children whose mothers used an often-prescribed type of antidepressant during pregnancy may be more likely to develop speech and language disorders, a new study suggests.
Researchers found that mothers who bought selective serotonin reuptake inhibitor (SSRI) drugs at least twice during pregnancy were 37 percent more likely to have a child with a speech and/or language disorder than those who did not take the antidepressants.
SSRIs include medicines such as Celexa, Lexapro, Paxil, Prozac and Zoloft.
The study was observational, meaning it couldn't prove that the drugs helped cause the language/speech problems, only that there was an association. And experts who reviewed the findings stressed that women who require an SSRI during their pregnancy may still want to stick with the drug.
"It must be remembered that the prevalence of speech-language disorders was very low in all of the offspring studied -- including those infants exposed to SSRIs prenatally," said Dr. Andrew Adesman. He's chief of child, developmental & behavioral pediatrics at Cohen Children's Medical Center in New Hyde Park, N.Y.
According to Adesman, "even if follow-up studies confirm that use of SSRIs during pregnancy modestly increase the risk of these offspring having a speech-language disorder, it is important to note that depression -- if untreated during pregnancy -- also poses significant risks to the mother."
The new study was led by Dr. Alan Brown, professor of epidemiology and psychiatry at Columbia University Medical Center in New York City. His team tracked data on more than 845,000 births in Finland between 1996 and 2010. The children were followed to age 3.
The study found that mothers who bought SSRI drugs at least twice during their pregnancy were 37 percent more likely to have a child with a speech and/or language disorder than those who did not take the antidepressants.
There was no link between SSRI use in pregnancy and the risk of either motor (movement) disorders or academic performance in children.
SSRIs are increasingly used during pregnancy to treat depression and other psychiatric disorders, the study authors noted, but they can cross the placenta and reach the fetus.
"To our knowledge, this is the first study to examine the relationship between maternal antidepressant use and speech/language, scholastic, and motor disorders in offspring," Brown said in a Columbia news release.
He stressed that a cause-and-effect relationship could not be proven, and other factors might explain the observed link.
For example, "the severity of maternal depression cannot be ruled out as an explanation for the increased childhood speech and language disorders" in children whose mothers took an SSRI, Brown said.
Adesman agreed that the issue is a complex one, and pregnant women shouldn't immediately stop taking an antidepressant based on these findings.
"Women who are taking SSRIs for depression and who are planning to get pregnant should discuss the risks and benefits of staying on their SSRI medication with their health care provider," Adesman said. He was not involved with the new study.
Dr. Jennifer Wu is an obstetrician/gynecologist at Lenox Hill Hospital in New York City. She agreed with Adesman, saying that "the important thing to remember is that the overall risk of speech and language disorders [for any child] is still very small."
She also stressed that an effective antidepressant is often essential for some women, so any risk to offspring "must be weighed against the risks of untreated depression. Mothers at risk for severe depression and suicide may not be able to stop their SSRIs."
The study was partially funded by the U.S. National Institutes of Health and was published online Oct. 12 in the journal JAMA Psychiatry.
The U.S. Office on Women's Health has more on pregnancy and medicines.
This article: Copyright © 2016 HealthDay. All rights reserved.